MedTrace Logo

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal

NCT00932945 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2010-09-14

No results posted yet for this study

Summary

Primary Objective:

To prove the safety of the gynecological formulation in normal conditions of use.

Conditions

  • Hygiene

Interventions

DRUG

LACTIC ACID(ND)

Treatment duration: 21 consecutive days

Sponsors & Collaborators

Principal Investigators

  • Jaderson Lima · Sanofi

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00932945 on ClinicalTrials.gov